STOCK TITAN

LifeVantage to Participate at the LD Micro Main Event XVII

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LifeVantage (Nasdaq: LFVN), a health and wellness company focusing on cellular-level health products, has announced its participation in the LD Micro Main Event XVII. The event will take place from October 28-30, 2024, in Los Angeles, CA. Steve Fife, President and CEO, and Carl Aure, CFO, will conduct investor meetings and deliver a presentation on October 30, 2024, at approximately 4:30 p.m. Eastern Time. The presentation will be available via live webcast on the company's Investor Relations website.

LifeVantage (Nasdaq: LFVN), un'azienda di salute e benessere focalizzata su prodotti per la salute a livello cellulare, ha annunciato la sua partecipazione al LD Micro Main Event XVII. L'evento si svolgerà dal 28 al 30 ottobre 2024, a Los Angeles, CA. Steve Fife, Presidente e CEO, e Carl Aure, CFO, condurranno incontri con gli investitori e presenteranno una relazione il 30 ottobre 2024, alle circa 16:30, ora orientale. La presentazione sarà disponibile tramite webcast dal vivo sul sito web delle Relazioni con gli Investitori dell'azienda.

LifeVantage (Nasdaq: LFVN), una empresa de salud y bienestar centrada en productos de salud a nivel celular, ha anunciado su participación en el LD Micro Main Event XVII. El evento se llevará a cabo del 28 al 30 de octubre de 2024, en Los Ángeles, CA. Steve Fife, Presidente y CEO, y Carl Aure, CFO, llevarán a cabo reuniones con inversores y realizarán una presentación el 30 de octubre de 2024, a aproximadamente 4:30 p.m. hora del Este. La presentación estará disponible a través de una transmisión en vivo en el sitio web de Relación con Inversores de la empresa.

LifeVantage (Nasdaq: LFVN)는 세포 건강 제품에 중점을 둔 건강 및 웰빙 회사로, LD Micro Main Event XVII에 참여한다고 발표했습니다. 이 행사는 2024년 10월 28일부터 30일까지 로스앤젤레스에서 열릴 예정입니다. 스티브 파이프 사장 겸 CEO와 칼 아우레 CFO가 투자자 회의를 진행하고, 2024년 10월 30일 동부 시간으로 오후 4시 30분경에 발표를 할 예정입니다. 발표는 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 제공될 것입니다.

LifeVantage (Nasdaq: LFVN), une entreprise de santé et de bien-être spécialisée dans les produits de santé au niveau cellulaire, a annoncé sa participation au LD Micro Main Event XVII. L'événement se déroulera du 28 au 30 octobre 2024 à Los Angeles, CA. Steve Fife, Président et CEO, et Carl Aure, Directeur financier (CFO), tiendront des réunions avec les investisseurs et effectueront une présentation le 30 octobre 2024, vers 16h30, heure de l'Est. La présentation sera disponible en direct via un webcast sur le site des relations avec les investisseurs de l'entreprise.

LifeVantage (Nasdaq: LFVN), ein Unternehmen für Gesundheit und Wohlbefinden, das sich auf zelluläre Gesundheitsprodukte konzentriert, hat seine Teilnahme am LD Micro Main Event XVII bekannt gegeben. Die Veranstaltung findet vom 28. bis 30. Oktober 2024 in Los Angeles, CA, statt. Steve Fife, Präsident und CEO, sowie Carl Aure, CFO, werden Investorenmeetings durchführen und am 30. Oktober 2024 um etwa 16:30 Uhr Eastern Time eine Präsentation halten. Die Präsentation wird live über das Investor Relations-Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

SALT LAKE CITY, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the LD Micro Main Event XVII, to be held October 28-30, 2024 in Los Angeles, CA.

Mr. Fife and Mr. Aure will meet with investors and present at approximately 4:30 p.m. Eastern Time on Wednesday, October 30, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here.

About LifeVantage Corporation

LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

When is LifeVantage (LFVN) presenting at the LD Micro Main Event XVII?

LifeVantage (LFVN) will present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 4:30 p.m. Eastern Time.

Where can I watch LifeVantage's (LFVN) LD Micro presentation?

The presentation can be viewed via live webcast on LifeVantage's Investor Relations website at https://lifevantage.gcs-web.com/

Which LifeVantage executives are participating in the LD Micro Main Event XVII?

Steve Fife, President and CEO, and Carl Aure, CFO, will participate in the event, conducting investor meetings and delivering the presentation.

What dates is the LD Micro Main Event XVII being held?

The LD Micro Main Event XVII is being held from October 28-30, 2024, in Los Angeles, CA.

Lifevantage Corporation

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Stock Data

171.41M
10.24M
16.9%
37.14%
2.06%
Packaged Foods
Pharmaceutical Preparations
Link
United States of America
LEHI